Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New app aims to help young people take control of chronic pain

NCT ID NCT02601755

Symptom relief Sponsor: The Hospital for Sick Children Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a smartphone app and website called iCanCope with Pain, designed to help teens and young adults (ages 15-25) manage chronic pain. The app lets users track pain, sleep, mood, and activity, set goals, and learn coping strategies. The goal was to see if the program is easy to use and whether it can improve pain, daily function, and quality of life. 302 participants from pain clinics took part.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
iCanCope smartphone app and website
What this could lead to
If it works, this could give teens and young adults a practical, self-guided tool to better manage chronic pain and improve daily life.
What could go wrong
This is a small, early-stage feasibility study focused on whether the program is usable and acceptable, not on proving it reduces pain. The app may not work for everyone or replace medical care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

302 people

The number who actually took part.

Started

Apr 2017

Finished

Aug 2023

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

15 to 25 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Diagnosed with chronic pain of at least 3 months duration according to medical chart * Able to speak and read English * Willing and able to complete online measures * Participants are active patients at pain clinic at one of the respective participating study sites * Have been on a stable dose of medications for at least 4 weeks prior to entering the study according to medical chart * Have access to an Internet-connected computer according to self-report. Exclusion Criteria: * Moderate to severe cognitive impairments, as assessed by reviewing medical chart and consultation with the patient's healthcare provider * Major co-morbid psychiatric (e.g. conversion disorder, depression, anxiety disorder) illness that may impact patient's ability to understand and use the iCanCope with Pain intervention via self-report, as determined by their health care provider * Patient from the department of haemology/oncology * Participated in the Phase 2B iCanCope usability study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic pain are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Chronic Pain chronic pain syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic pain

Contacts and locations

Locations

  • Alberta Children's Hospital

    Calgary, Alberta, T3B 6A8, Canada

  • Hamilton Health Sciences

    Hamilton, Ontario, L8N 3Z5, Canada

  • Hospital for Sick Children

    Toronto, Ontario, M5G 1X8, Canada

  • IWK Health Centre

    Halifax, Nova Scotia, B3K 6R8, Canada

  • Mount Sinai Hospital

    Toronto, Ontario, M5G 1X5, Canada

  • Nova Scotia Health Authority/Dalhousie University

    Halifax, Nova Scotia, B3H 2E1, Canada

  • Stollery Children's Hospital

    Edmonton, Alberta, T6G 2B7, Canada

  • The Ottawa Hospital

    Ottawa, Ontario, K1H 8L6, Canada

  • University of Alberta

    Edmonton, Alberta, T6G 2R7, Canada

  • University of Saskatchewan

    Saskatoon, Saskatchewan, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.